(S)-2,2'-Dimethoxy-1,1'-binaphthalene, ��97.0%, 100g

2-Fluoro-4-methyl-5-(4-(trifluoromethoxy)phenyl)pyridine, 97%, 500mg

4-(3,4-Difluorophenoxy)aniline, 95%, 100mg

2-Bromo-6-chlorothieno[2,3-b]pyridine, 95.0%, 5g

Tissus durs ROTI® SampleLyse, 6 pièces 6 pièces

Colonne capillaire GC ROTI®Cap-1701 MS, 30 m, 0,25 mm, 0,25 µm, 1 pièce(s)

3-(ethoxycarbonyl)-5-methyl-1-(2-methylphenyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

3,4-Dichloropyridine, 98.0%, 1g

7-BROMO-2-METHYL-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 97.0%, 1g

4-(Methoxycarbonyl)thiophene-2-carboxylic acid, 98%, 500mg

2-(2-(Bromomethyl)-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

5-Bromo-2-hydroxypyrimidine>95.0%(GC)5g

5-Bromo-2-hydroxypyridine, 98.0%, 5g